RankAlpha logo
Back to Rankings

DVA

DaVitaA
NYSE / Health Care Equipment & Services
Last Price
At close
2026-07-21
View Chart
Current thesis
The primary bull argument is that DaVita is still converting modest treatment growth and reimbursement tailwinds into strong cash generation, raised full-year guidance in the May 5, 2026 release, and is using large buybacks to amplify per-share results. IKC scale also offers a non-traditional growth lever.
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Leverage remains material: the Q1 release showed about $10.0 billion of net debt and a 3.34x leverage ratio, leaving less room for execution misses even though covenant headroom remains.
Momentum
87
Value
67
Sentiment
36
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $160.00 · Bull $220.00 · Bear $130.00
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-16 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $217.33
Why
Momentum87 · Δ7d -4.0
Value67 · Δ7d +0.0
Sentiment36 · Δ7d -0.6
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
87
26% active weight
Current posture
7d trendSoftening
Δ7d
-4.0
Δ21d
+1.2
Value
67
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.3
Sentiment
36
34% active weight
Current posture
7d trendFlat
Δ7d
-0.6
Δ21d
-7.4
Why this grade

Composite grade A. Momentum 87.2 / Value 66.9 / Sentiment 35.7

Fundamentals (TTM)
As of 2026-07-21
Market Cap
$15.23B
Beta
0.99
Shares Out
64.2M
P/E (TTM)
11.7
P/S (TTM)
0.60
P/FCF (TTM)
6.22
Rev YoY
+6.0%
EPS YoY
+43.1%
Gross Margin
+27.3%
Op Margin
+15.3%
Net Debt
$12.29B
Current Ratio
1.42
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology